Recombinant human growth hormone (rhGH) is being used to promote linear growth in short children with Noonan syndrome. However, its efficacy is still controversial.
Giacomozzi, C., Deodati, A., Shaikh, M., Ahmed, S., Cianfarani, S. (2015). The impact of growth hormone therapy on adult height in noonan syndrome: A systematic review. HORMONE RESEARCH IN PAEDIATRICS, 83(3), 167-176 [10.1159/000371635].
The impact of growth hormone therapy on adult height in noonan syndrome: A systematic review
Deodati, A;CIANFARANI, STEFANO
2015-01-01
Abstract
Recombinant human growth hormone (rhGH) is being used to promote linear growth in short children with Noonan syndrome. However, its efficacy is still controversial.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
